Novel abciximab-Kruppel-like factor 4-plasmid dual-delivery titanium dioxide-coated coronary stent

Int J Cardiol. 2013 Oct 12;168(5):5104-6. doi: 10.1016/j.ijcard.2013.07.247. Epub 2013 Aug 2.
No abstract available

Keywords: Coronary stent; Drug; Dual delivery; Gene.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abciximab
  • Animals
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / metabolism
  • Coronary Vessels / metabolism
  • Coronary Vessels / pathology
  • Drug Delivery Systems / methods*
  • Drug-Eluting Stents*
  • Gene Transfer Techniques*
  • HEK293 Cells
  • Humans
  • Immunoglobulin Fab Fragments / administration & dosage*
  • Immunoglobulin Fab Fragments / metabolism
  • Kruppel-Like Factor 4
  • Kruppel-Like Transcription Factors / administration & dosage*
  • Kruppel-Like Transcription Factors / metabolism
  • Male
  • Swine
  • Titanium*

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • KLF4 protein, human
  • Kruppel-Like Factor 4
  • Kruppel-Like Transcription Factors
  • titanium dioxide
  • Titanium
  • Abciximab